Rankings
▼
Calendar
ORIC Q2 2019 Earnings — ORIC Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
ORIC
ORIC Pharmaceuticals, Inc.
$1B
Q2 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$6M
Net Income
-$6M
EPS (Diluted)
$-0.31
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$6M
Stock-Based Comp.
$190,000
← FY 2019
All Quarters
Q3 2019 →
